• For the first time, Chaberton Energy makes Inc. Magazine’s Inc. 5000 list, placing No. 34, with three-year revenue growth of 7,300%.
• The Maryland-based, national solar developer is the third-fastest growing energy company on this year’s Inc. 5000 list, underscoring the company’s position as one of America’s top start-up clean energy companies after only four years since its founding.

ROCKVILLE, Md., Aug. 13, 2024 — Chaberton Energy today was ranked No. 34 on this year’s Inc. 5000, the most prestigious ranking of America’s fastest growing privately held companies. This is the company’s first time being named to the list.

The Maryland-based national solar developer achieved profitability in its second year of operations and has seen 73x revenue growth since its founding in February 2020. Chaberton is the second-fastest growing company in Maryland on this year’s Inc. 5000 list and is the nation’s third-highest ranked energy company. Chaberton is also the fastest growing community solar company on the list.

“We are so humbled by the recognition from Inc. Magazine, and while we have only been in business for less than five years, this award validates all the hard work and thoughtfulness that our entire team has put into fulfilling a vision we had from the beginning,” said Stefano Ratti, Chaberton’s CEO and founder. “Our company values of creativity, excellence, and humanity formed the building blocks to this amazing growth story, and they will continue to fuel our growth well into the future.”

The Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and hiring challenges. Among this year’s top 500 companies, the average median three-year revenue growth rate is 1,637%. In all, this year’s Inc. 5000 companies have added 874,458 jobs to the economy over the past three years.

Chaberton develops solar projects for businesses and for communities. These projects save money, provide access to clean energy for communities and residents who may not be able to have their own solar arrays, and support economic growth and environmental justice. The company is active in Maryland, Delaware, Virginia, New Jersey, Ohio, Illinois, New Mexico and California, among others, focusing on states with supportive solar and clean energy policies.

This year the company announced that it was developing solar projects at more than 100 sites. It has gone from zero project pipeline in 2020 to 740 megawatts of electric generating capacity in just four years. That’s enough to power roughly 128,000 homes and eliminate 770,000 tons of carbon emissions each year.

Chaberton’s top-two ranking in Maryland highlights the company’s position as a leading community solar developer in its home state. As of this July, Chaberton has over 60 megawatts of community solar generating capacity completed or under development in the state.

“Chaberton is demonstrating how states with strong community solar policies can develop impactful clean energy projects that support the transition to renewables while directly helping residents,” said Erica Brinker, Chaberton’s Chief Commercial and Sustainability Officer “As the world makes the necessary transition to affordable, economy-building clean energy sources, Chaberton will be here to help. We can’t wait to see what tomorrow holds.”

As a public benefit corporation, Chaberton has achieved its impressive growth while doing good for the communities it serves. Chaberton builds on this commitment with Chaberton Cares. Through this program, Chaberton provides direct funding to nonprofit organizations local to its solar projects. For every megawatt of new community solar capacity Chaberton develops, the company provides $5,000 per megawatt in funding to local organizations.

In 2020, Chaberton received a corporate-level investment from Greenbacker’s Development Opportunities Fund (GDEV), which makes corporate investments in sustainable infrastructure development companies. Managing director and group head of GDEV, Ben Baker shares, “We are proud to be a part of Chaberton’s story and look forward to their continued success. The discipline that led to this growth, further enabled by GDEV’s catalytic capital, is something we all should be proud of.”

About Chaberton Energy 

Headquartered in Maryland, Chaberton Energy is a public benefit corporation focused on developing sustainable infrastructure and renewable energy projects. Chaberton’s work ranges from site conception to full operations, emphasizing distributed energy, community solar, and commercial and industrial initiatives.

Chaberton deeply values the communities it serves, including employees, landowners, neighbors, customers, regulators, development partners and investors. Rooted in creativity, excellence and humanity, the Chaberton team is dedicated to creating sustainable renewable energy solutions. These projects not only support the transition to clean energy and reduce pollution, but they also benefit residents and businesses economically. Learn more at chaberton.com.

More about the Inc. 5000

Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth from 2020 to 2023. To qualify, companies must have been founded and generating revenue by March 31, 2020. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2023. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2020 is $100,000; the minimum for 2023 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to four decimal places.

Chaberton Media Contact 
Erica Brinker
412.715.3652
[email protected]

SOURCE Chaberton Energy

CHICAGO, Aug. 13, 2024 — Livly, a leading provider of technology-driven residential management platforms, has announced the successful completion of a third investment round. The $10M in funding will support several new initiatives designed to increase net operating income for developers, property operators, and third-party property management companies.

“We’re committed to delivering unparalleled value and return on investment by providing a highly engaged platform that enhances the quality of life for all stakeholders in multifamily properties,” stated CEO Alex Samoylovich. “This new round of funding will enable us to expand our market presence further and develop innovative products and services that deliver even greater value to residents, property owners, and operators.”

The investment will fuel Livly’s expansion into new markets and support the development of cutting-edge technology solutions to enrich resident experiences and optimize property management processes. Anticipated enhancements include increased access and IoT integrations and expanded AI functionality in maintenance, touring, and sentiment analysis.

“We are thrilled to receive robust support for our vision and validation of our original hypothesis from both institutional and strategic investors,” remarked Executive Chairman Brian Duggan. “This funding solidifies Livly’s position as a leader in the prop-tech industry and will enable us to continue delivering innovative solutions that set new standards for the multifamily housing sector.”

Livly’s advanced apartment technology offers a modern and user-friendly alternative to traditional prop-tech offerings within the industry. Through Livly’s platform and app, property operators can seamlessly manage community events, resident communication, maintenance requests, package deliveries, rent payments, and amenity reservations—all within a centralized digital hub. Additionally, Livly’s portfolio management capabilities, AI-powered Maintenance assistant, and advanced analytics for renewal predictor scores and overall sentiment provide valuable insights and efficiencies to enhance operational performance.

About Livly, Inc.

Founded in 2017, Livly has built the first enterprise-grade resident operating system combining both technology and services which acts as the connective tissue within resident communities and an intuitive remote-control to apartment living. Livly’s suite of mobile and web applications offer a one-app solution for property management teams and residents to deliver an improved resident experience, streamline building operations, and increase property NOI. For more information, please visit Livly’s website at www.livly.io.

SOURCE Livly

SAN FRANCISCO, Aug. 13, 2024 — Today PayZen, a technology company tackling healthcare affordability with AI-powered solutions, announced an oversubscribed Series B, led by NEA, with full participation from existing investors including 7wireVentures, SignalFire, Viola Ventures, and others. The round includes $32M Equity and a new $200M credit warehouse from Viola Credit and a syndicate of insurance companies. This additional credit facility will support its continued rapid growth and market expansion.

Leveraging proprietary AI/ML models, automation, and seamless integration into EMR/EHR systems, PayZen simplifies the patient payment process for health systems while making it easier for millions of patients to access and afford the care they need. Specifically, its award-winning, data-driven, personalized payment plans ease the financial burden for patients while improving financial results for health systems. PayZen has spearheaded a culture of innovation and high-quality delivery in the Revenue Cycle Management market, challenging the status quo that has left many patients unable to afford care and has exacerbated the friction and administrative burden on healthcare providers.

Over the last 2 years, PayZen has consistently achieved a remarkable 6x YoY growth. It also boasts 100% customer retention and 132% net retention. PayZen aims to continue this momentum into the second half of 2024, bringing its affordable, customized healthcare payment options to even more Americans and introducing new AI-driven solutions that further address the affordability needs of patients.

“This latest round is the next step in our journey to remove financial barriers to care for patients,” says Itzik Cohen, CEO & Co-Founder at PayZen. “We are honored to have found partners in both our investors and our health systems network that share the same vision for the future. This milestone, marked by a highly competitive and oversubscribed round, positions us to continue perfecting our platform and bridge healthcare’s financial gap for good.”

In conjunction with the financing, Mohamad Makhzoumi, Co-CEO, NEA, will be joining PayZen’s Board of Directors. Makhzoumi has more than two decades of experience at NEA, partnering with transformative healthcare startups across all stages of company-building.

“Healthcare affordability is an enormous pain point for patients and providers in the U.S.,” says Makhzoumi. “We believe PayZen’s AI-enabled platform is a category leader, as evidenced by the company’s explosive traction in the past year and ability to disrupt a market that’s been historically difficult to address. Itzik and the PayZen team are driving positive change in healthcare payments, and we’re thrilled to partner with them on this next phase of growth and expansion.”

About PayZen
PayZen is a mission-driven healthcare fintech company that is solving the growing patient payment responsibility problem with superior technology and a modern approach. PayZen is backed by leading equity and credit capital investors and is led by proven technology veterans with a successful track record of helping millions of Americans overcome financial struggles. To learn more about PayZen, please visit https://payzen.com.

Contact
Kathy Osborne
[email protected] 

SOURCE PayZen

CLEVELAND, Aug. 13, 2024 — Ohio VC Fest, the state’s leading venture capital event, will take place September 17-18, 2024, at the Huntington Convention Center of Cleveland. Hosted by JumpStart and JumpStart Ventures, this annual two-day event will bring together over 500 startups, investors, industry leaders and policymakers.

“Ohio VC Fest is a place where visionary ideas evolve into successful businesses simply by pulling the right people together,” said Julie Jacono, CEO of JumpStart and JumpStart Ventures. “This summit brings together the change makers needed to boost Ohio’s startup scene. It’s about making real connections and empowering entrepreneurs to thrive.”

Showcasing Ohio as a premier destination for tech startups and venture capital investments, Ohio VC Fest features curated one-on-one meetings, expert sessions and networking opportunities to spark meaningful connections.

The summit promises to infuse new capital into the state to accelerate VC investment, drawing over 75 venture investors representing more than $1B under management to Cleveland. This premier event will create opportunities for Ohio-based startups to build valuable partnerships with top firms from the coasts and the Midwest, including Advantage Capital, Fulcrum Equity Partners, and Edison Partners.

Ohio VC Fest ’24 is presented by Cyrannus, a trailblazing venture capital disruptor offering the first AI-powered platform utilizing industry experts to rapidly evaluate promising seed-stage startups at scale, delivering a safe harbor and liquidity to investors. During the two-day event, Cyrannus will award a $40K investment to one Ohio-based company and provide $10K in non-dilutive capital to another deserving startup.

Ohio VC Fest ’24 will include over six hours of Venture Connection meetings across two days. Founders, investors and corporates will be matched based on fit, delivering targeted elevator pitches and co-investment opportunities.

In addition to the matchmaking sessions, Ohio VC Fest offers a diverse program of workshops and panels where industry thought leaders can share insights and inspire new ideas. This year, the event also boasts an expanded demo hall, with 30 Ohio-based tech startups selected through a rigorous screening process showcasing health tech, software, hard tech and sports tech innovations.

This event is possible thanks to sponsors, including Thompson Hine, JobsOhio, Big Kitty Labs, Rev1 Ventures, Cleveland Clinic, Silverline Consulting and many others. Registration is now open. To purchase tickets and learn more, visit OhioVCFest.com.

About JumpStart
JumpStart is a nationally recognized venture development organization that provides capital, services and connections to help entrepreneurs grow. In 2024, JumpStart celebrates 20 years of empowering entrepreneurs and driving regional economic impact through its comprehensive support services and investments across Ohio. To learn more, visit jumpstartinc.org.

About JumpStart Ventures
JumpStart Ventures is a division of JumpStart investing in Seed and Series A-stage technology startups throughout Ohio and beyond. With four investment funds under management, the organization provides a continuum of capital to startup founders as they move through critical growth phases. To learn more, visit JumpStart.VC.

SOURCE JumpStart Inc.

Led by Frist Cressey Ventures, the round will help drive MD Ally’s mission to enhance public safety and health care systems

NEW YORK, Aug. 13, 2024 — MD Ally, a leader in 911 diversion, care, and navigation solutions, announced the successful completion of a $14 million Series A funding round. This brings MD Ally’s total funding to $25 million.

This round was led by Frist Cressey Ventures, founded by Senator Bill Frist and Bryan Cressey, and anchored by General Catalyst, with participation from Techstars, Seae Ventures, Red & Blue Ventures, and Alumni Ventures.

MD Ally is tackling a critical issue in emergency medical services, the overwhelming influx of millions of non-emergency 911 calls. These calls strain EMS systems, increase ambulance wait times, overcrowd emergency rooms and drive unnecessary healthcare costs. By collaborating with public safety systems and health insurance payors, MD Ally’s 911 virtual care program ensures that callers with non-emergency concerns receive timely, appropriate, and convenient care.

“We are excited to partner with Shanel Fields and the MD Ally team to identify and expand public safety collaborations and improve emergency services. The MD Ally model is nationally unique and highly effective in ensuring more patients receive personalized care, along with comprehensive care navigation and coordinated follow up care,” said Senator Bill Frist, M.D., co-founder and managing partner of Frist Cressey Ventures.

In addition to saving $2,280 in healthcare costs on average, callers also receive a “personal assistant” level of support to tackle treatment plan tasks and ensure adherence for better long-term patient care outcomes. This approach not only delivers more personalized care to patients but also keeps ambulances available for true emergencies.

“The nice thing about MD Ally is they have this blanket system that works for any agency,” said Colin Johnson, Lee County, Florida’s Deputy Chief of EMS during a recent interview with Bloomberg News.

MD Ally was also recently recognized as the “Most Innovative Civic Tech Company” by the US Conference of Mayors.

The company is partnering with some of the largest cities in the US like Phoenix, AZ and implementing several national payor partnerships across Florida, Arizona, and California to serve over 5 million patients. The newly secured funding will enable MD Ally to open up access to its solution to other forward-thinking public safety and payor partners that have been waiting to achieve similar outcomes. This growth will further enhance the company’s 911 and EMS-integrated technology, expand clinical services, and extend downstream care coordination partnerships.

“This funding marks a key milestone for MD Ally,” said Shanel Fields, Founder & CEO of MD Ally. “Our goal is to implement revolutionary, non-emergency 911 care pathways, ensuring that patients receive the right level of care quickly and efficiently. We’re “officiating” historic partnerships between public safety systems and payors that have already significantly improved patient outcomes. With the support of new partners like Frist Cressey, and continued support from existing investors like General Catalyst, we are poised to recruit even more incredible talent, expand our impact nationwide, and successfully tackle a challenge that drives over $31.5B in excess costs every year.”

About MD Ally

Founded in 2018 by the daughter of an EMT volunteer, MD Ally is focused on eliminating the logistical barriers that often prevent impactful partnerships between 9-1-1 and the broader healthcare ecosystem. With MD Ally, medical dispatch and response systems are able to implement a 9-1-1 telehealth solution that expands the scope of services they can provide to their community. To learn more about MD Ally, visit www.mdally.com.

About Frist Cressey Ventures

Frist Cressey Ventures (FCV) is a leading healthcare venture capital firm focused on accelerating the growth of high potential healthcare companies through value-added partnerships. Our mission is simple: to transform healthcare to improve lives. We invest in early-stage startups that build technology or services that advance quality of care, system integration, patient outcomes, affordability, and access. To learn more about Frist Cressey Ventures, visit our website at www.fcventures.com.

SOURCE MD Ally

Both companies are exhibiting at the upcoming AI Summit

SILICON VALLEY, Calif., Aug. 13, 2024 — Movellus today announced that it has joined the Silicon Catalyst ecosystem as the newest member of their In-Kind Partner (IKP) network.  Silicon Catalyst is the only incubator + accelerator focused on the global semiconductor industry including Chips, Chiplets, Materials, IP and Silicon fabrication-based Photonics, MEMS, Sensors, Life Science and Quantum. The Silicon Catalyst IKPs provides technical and business support to the Portfolio Companies in the incubator + accelerator, enabling them to tap into the products and services available to enhance the growth of their companies.

Silicon Catalyst Portfolio Companies will now have access to the Movellus high-performance energy and performance-optimized infrastructure IP for their complex SoCs. The Movellus Aeonic™ Digital IP platform comprises product families targeted at: on-die sensing to provide visibility required to solve significant challenges like SDC (Silent Data Corruption), digital clocking which allows for architectural innovation through novel strategies like per-core distributed clocking or fine-grained DVFS (Digital Voltage and Frequency Scaling), and on-die power delivery to maximize energy savings through per-core DVFS. End applications range from ultra-low power edge AI devices to performance-centric cloud datacenter compute and AI offerings.

Lee Vick, Vice President of Strategic Marketing, Movellus
“Movellus is excited to be working with the incredible community of start-ups that Silicon Catalyst has enabled. The inevitable migration from yesterday’s analog clocking approaches to the smaller, distributed, observable digital clocking architectures that feed silicon lifecycle analytics platforms is happening now. It is the forward-thinking companies in the Silicon Catalyst portfolio that are leading the charge for innovative architectures required to develop modern AI chips and other leading-edge SoCs.”

Pete Rodriguez, CEO, Silicon Catalyst
“Adding Movellus as our latest IKP extends our ability to provide the most advanced IP available to our start-ups. The billions of transistors required to develop industry leading solutions will necessitate modular digital designs, and Movellus is the undisputed leader in digital clocking technologies. This collaboration with Movellus will help tool the next generation of silicon startups with observable and energy-optimized infrastructure IP.”

Silicon Catalyst has developed an unparalleled support ecosystem for its semiconductor start-ups, providing a strong network of financiers, business advisors, and industry professionals who help companies to launch and scale in the market. In addition, the incubator provides privileged access to services, expertise, and intellectual property from the comprehensive network of In-Kind Partners that can empower their companies’ technological innovation and business growth.

AI Hardware Summit Exhibition – September 10-12, 2024 in San Jose
To learn more about Movellus and Silicon Catalyst, meet us at the upcoming AI Hardware and Edge AI Summit, https://aihwedgesummit.com/events/aihwedgesummit

Movellus will be showcasing its award-winning IP portfolio for energy optimization at Booth 68. Silicon Catalyst will be exhibiting in the AI Innovation Village, with personnel from the incubator and the Silicon Catalyst Ventures team to meet with attendees. The show floor will be open from September 10^th to 12^th at the Signia by Hilton in San Jose, California.

Silicon Catalyst is pleased to offer a specially arranged discount to attend this important industry event; Discount Code: SILICONCATALYST15 for 15% off the conference registration fee. This limited time offer expires August 19, 2024.

About Movellus
Movellus provides critical infrastructure IP for complex SoCs in the AI era.  Movellus IP is integrated into an array of applications ranging from edge AI devices to performance-centric cloud datacenter compute and networking offerings. The company is headquartered in Sunnyvale, CA, with R&D centers in Michigan and Toronto. Visit us at: www.movellus.com

Movellus, the Movellus logo, Aeonic, Aeonic Generate, Aeonic Power, Elevating Silicon, Aeonic Insight, and Intelligent Clock Networks are among the trademarks of Movellus. The term “Movellus” refers to Movellus Circuits Inc and/or its subsidiaries. Other trademarks are the property of their respective owners.

About Silicon Catalyst “It’s about what’s next”
Silicon Catalyst is the world’s only incubator focused exclusively on accelerating semiconductor solutions, built on a comprehensive coalition of in-kind and strategic partners to dramatically reduce the cost and complexity of development. More than 1200 startup companies worldwide have engaged with Silicon Catalyst over the past 9 years and the company has admitted over 100 exciting companies. Silicon Catalyst supplies startups with access to design tools, silicon devices, networking, and a path to funding, banking and marketing acumen to successfully launch and grow their companies’ novel technology solutions. The Silicon Catalyst model has been proven to dramatically accelerate a startup’s trajectory while at the same time de-risking the equation for investors. With a world-class network of mentors to advise startups, Silicon Catalyst is helping new semiconductor companies address the challenges in moving from idea to realization.

The Silicon Catalyst Angels was established in July 2019 as a separate organization to provide access to seed and Series A funding for Silicon Catalyst portfolio companies. Additionally, the Silicon Catalyst Venture group was recently launched to provide funding to newly admitted companies to the Silicon Catalyst incubator + accelerator. More information is available at www.siliconcatalyst.com, www.siliconcatalyst.uk, www.siliconcatalystangels.com and www.sicatalystvc.com

Press Contacts

Movellus
Anika Karvat
(503) 545-6320
[email protected] 

Silicon Catalyst
Richard Curtin
[email protected] 

SOURCE Movellus

• Inclusive trial recruiting women and men with androgenetic alopecia to evaluate safety and preliminary efficacy of PP405, a topical treatment designed to reactivate dormant hair follicle stem cells
• $14M financing led by GV (Google Ventures) to accelerate Phase 2 clinical program
• Leaders in dermatology join Clinical Advisory Board (CAB) to advance clinical development

LOS ANGELES, Aug. 13, 2024 — Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a new generation of treatments for hair loss, today announced that the first patients have been dosed in its Phase 2a clinical trial evaluating the safety and efficacy of PP405, a novel topical small molecule, for the treatment of androgenetic alopecia (pattern baldness). The company is enrolling 60 women and men for the clinical study. PP405 is designed to reactivate dormant hair follicle stem cells to stimulate hair growth.

Pelage also raised a $14 million Series A-1, led by GV, following an initial $16.75 million Series A financing announced in February 2024. The Series A-1 follows positive Phase 1 data, which demonstrated proof of mechanism and target engagement in patients with androgenetic alopecia, supporting a Phase 2 study.

“The advancement of our lead program, PP405, into Phase 2a is a pivotal moment in our journey to deliver a non-invasive, innovative treatment for androgenetic alopecia across all genders, skin types, and hair types,” said Qing Yu Christina Weng, M.D., Chief Medical Officer, Pelage Pharmaceuticals. “We are excited to include women and men of all skin tones and hair textures, which has not always been the case in hair loss studies.”

PP405 addresses the metabolic processes that regulate activation of hair follicle stem cells. In androgenetic alopecia, the normal growth cycle of hair is disrupted due to a combination of genetics, age, hormones, and environmental factors, but the follicles and stem cells remain intact. PP405 is based on the discovery of a molecular switch that specifically targets hair follicle stem cells to reactivate dormant processes and restore the growth cycle of hair.

The Phase 2a trial (NCT06393452) is a randomized, placebo-controlled study of PP405 in women and men with androgenetic alopecia. Also known as pattern balding, it is the most common form of alopecia and will affect most people throughout their lives. Study participants will receive a daily topical application of PP405 or a placebo. Participants of all skin phototypes and hair types and textures are eligible. Those interested in participating can find the information at this link.

“GV is encouraged by Pelage’s prior Phase 1 data readouts and robust clinical safety profile,” said Cathy Friedman, Executive Venture Partner, GV and Board Director, Pelage Pharmaceuticals. “We believe the expert team at Pelage is well-positioned to advance this novel and innovative hair loss research, providing a potential alternative to existing treatments that simply slow hair loss.”

Along with the Phase 2a trial, Pelage has announced the formation of its Clinical Advisory Board (CAB), which will support the company’s strategic initiatives as it advances its clinical programs. 

The newly appointed members are:

• Mathew Avram, M.D., J.D., F.A.A.D., Director, Massachusetts General Hospital Dermatology Laser & Cosmetic Center and Associate Professor of Dermatology, Harvard Medical School
• Amelia K. Hausauer, M.D., F.A.A.D., Director of Dermatology and Minimally Invasive Aesthetics at Aesthetx
• Amy McMichael, M.D., F.A.A.D., Professor and past Chair, Department of Dermatology at Wake Forest School of Medicine
• Arash Mostaghimi, M.D., M.P.A., M.P.H., F.A.A.D., Associate Professor of Dermatology, Vice Chair of Clinical Trials and Innovation, and Director of the Dermatology Inpatient Service at Brigham & Women’s Hospital/Harvard Medical School

“The compelling science behind Pelage’s approach signals an exciting opportunity to potentially reverse the effects of alopecia, an issue I see daily in my clinical practice,” said Dr. Avram. “Hair loss impacts an incredibly diverse patient population, which should be reflected in early clinical trials. We’re focused on guiding the study design to support the inclusion of participants that reflect the diversity of people affected by hair loss.”

About Pelage Pharmaceuticals

Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing novel treatments for hair loss including androgenetic alopecia and chemotherapy-induced-alopecia. With a focus on molecular and stem cell biology, Pelage is advancing a new class of treatments designed to reactivate dormant hair follicle stem cells and restore the body’s ability to naturally grow hair. Its lead program, PP405, is currently in clinical trials. Through its rigorous scientific foundation, Pelage is pioneering first-in-class hair growth solutions for people of all hair types experiencing hair loss.

About PP405

PP405 is a novel, non-invasive, topical small molecule designed to reactivate dormant hair follicle stem cells and restart hair growth. Through a regenerative medicine approach, the treatment focuses on addressing the metabolic processes that regulate the activation and inactivation phases of hair follicle stem cells. Early results from a Phase 1 trial show that PP405 was well-tolerated and demonstrated statistically significant activation of hair follicle stem cells. In 2018, Pelage Pharmaceuticals licensed the intellectual property to PP405 and related topical small molecules from the University of California. PP405 is currently in Phase 2a clinical evaluation to assess safety and preliminary efficacy in adults with androgenetic alopecia (NCT06393452).

SOURCE Pelage Pharmaceuticals

Strategic Investment to Accelerate PROBIS’ AI-Powered Financial Management Solutions for Real Estate Development and Support Global Expansion

CHICAGO, Aug. 13, 2024 — JLL today announced that its corporate venture capital arm, JLL Spark Global Ventures, has led the Series A investment round in PROBIS, a company specializing in financial management for real estate development through AI and benchmark technology.

PROBIS aims to advance the real estate industry by replacing outdated financial management systems. The PROBIS platform offers comprehensive financial control of development projects and enhances cost and revenue management through advanced AI-based technology. JLL Spark’s investment helps position PROBIS for substantial growth in the cloud-based project controlling sector.

“JLL’s investment is a continuation of our global expansion strategy,” said Moritz Koppe, CEO of PROBIS. “Their involvement enables us to grow and offer our customers additional cloud-based AI functions that expand our capabilities in multi-project controlling and the provision of real-time data for real estate lenders and developers.”

JLL Spark focuses on investing in PropTech companies that deliver innovative solutions to the real estate industry. The strategic investment in PROBIS aims to drive digital transformation and efficiency within the industry. The partnership will enable PROBIS to leverage JLL’s extensive resources and JLL Spark’s expertise in PropTech and FinTech, further advancing its software solutions.

“After extensive evaluation, we determined that PROBIS’ financial management technology represented a great fit for JLL and its clients, as well as a highly compelling investment opportunity for JLL Spark,” said Sean Wright, Principal at JLL Spark in EMEA. “We’re excited about the prospects of this partnership and look forward to working with the PROBIS team in the years ahead.”

“The investment in PROBIS marks a pivotal step in JLL’s digital transformation within our Project & Development Services,” said Dunja Nigrin, Head of Project & Development Services DACH at JLL. “By combining PROBIS’ AI-driven solutions with our industry expertise, we are poised to redefine project and development management, offering clients efficient, automated oversight from planning to completion. This collaboration underscores our commitment to establishing new standards in ESG, revenue, and construction cost control, ultimately delivering enhanced value and savings for our clients.”

The Series A funding round underscores PROBIS’ commitment to leveraging technology for enhanced AI-based financial control and calculations. This partnership promises substantial progress in the digitalization of the real estate industry.

About PROBIS

PROBIS, headquartered in Munich, provides a scalable cloud-based platform for efficient and transparent financial process management, targeting real estate owners, banks, project developers, and investors. Founded in 2022, PROBIS has rapidly become a leading multi-project controlling software in the real estate and finance sectors, known for ensuring cost security and control from early project stages. With up to 1,000 completed projects annually and a management team with 20 years of experience in digital cost control for major developments like airports, hotels, soccer stadiums, and office buildings, PROBIS is a trusted partner. The platform’s comprehensive services and user-friendly processes facilitate seamless planning, control, and optimization of projects and portfolios. For more information, visit https://en.prob.is/. 

About JLL Spark 

JLL Spark Global Ventures is the corporate venture arm of JLL and a part of the JLL Technologies division. Founded in 2017, JLL Spark offers JLL the ability to provide innovative products and data-driven solutions to real estate owners, occupiers, and users. The JLL Spark fund is run by experienced Silicon Valley VCs and entrepreneurs with successful track records building and investing in tech companies. JLL Spark has invested over $390 million since June 2018 in more than 50 early-stage PropTech startups with underlying investment themes of data and sustainability, across construction tech, financial tech, smart buildings, future of work, and industrial tech. For more information, please visit https://spark.jllt.com. 

About JLL

For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500 company with annual revenue of $20.8 billion and operations in over 80 countries around the world, our more than 110,000 employees bring the power of a global platform combined with local expertise. Driven by our purpose to shape the future of real estate for a better world, we help our clients, people and communities SEE A BRIGHTER WAY^SM. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.

Contact: Lesley Mirkowski
Phone: +1 312 228 2112
Email: [email protected]

SOURCE JLL

PALO ALTO, Calif., Aug. 12, 2024 — NEXT Insurance, a leading digital insurer transforming small business insurance, announced it has been named to CNBC’s inaugural list of the World’s Top Insurtech Companies of 2024 in the digital insurer category. The global list is published by CNBC in partnership with market research firm Statista.

“Our recognition from CNBC underscores the transformative power of our early investment in technology to revolutionize small business insurance and address a critical market gap in the industry,” said Guy Goldstein, CEO of NEXT Insurance. “As a digital-first insurance provider, we’re well underway to lead the market into a new era and to deliver outstanding products and services to our customers, partners and agent ecosystem.”

CNBC’s list of The World’s Top Insurtech Companies of 2024 highlights the top insurtech companies globally and includes companies from six different market categories: Underwriting & Risk Analysis, Policy Administration & AdminTech, Claim & Fraud Management, Marketing, Sales, and Distribution, Digital Brokerage & Comparison Platforms, and Digital Insurers. To select the top companies, Statista analysts conducted in-depth research into relevant KPIs for over 1,000 eligible companies between March and May 2024. The digital insurer category includes insurance carriers and Managing General Agents (MGAs) that use technology to offer a personalized, flexible insurance experience online.

NEXT helps over half a million small businesses nationwide thrive by providing simple and tailored business insurance. As a vertically integrated, technology-led, full-stack insurer, NEXT provides an end-to-end digital experience for customers that includes writing policies, claims handling, pricing, servicing, and underwriting. The company has raised over $1.1 billion in venture capital funding, including a recent $265 million strategic investment from Allstate and Allianz X.

About NEXT Insurance
NEXT Insurance is transforming small business insurance with simple, digital coverage tailored to the self-employed. Trusted by over 500,000 business owners, NEXT offers policies that are easy to buy and provides 24/7 access to Certificates of Insurance, additional insured, and more, with no extra fees. Revolutionizing a historically complicated insurance industry, NEXT utilizes AI and machine learning to simplify the purchasing process. Founded in 2016, the company is headquartered in Palo Alto, has received a total of $1.1 billion in venture capital funding, is rated “A- Excellent” by AM Best and has been recognized by CNBC Disruptor 50, Forbes Fintech 50, Inc.’s Best-Led Companies, and Forbes Best StartUp Employers. For more information, visit NEXTInsurance.com. Stay up to date on the latest with NEXT on Twitter, LinkedIn, Facebook and our blog.

Media Contact
Kerry Ogata
Director of Corporate Communications
301-717-4224
[email protected]

SOURCE NEXT Insurance